Skip to content
Health Horizon

Health Horizon

Healthy Body Your Time in Health

Primary Menu Health Horizon

Health Horizon

  • Health Horizon
  • Health Technology Innovation
  • Global Health and the Health Crisis
  • Mental Health and Emotional Wellbeing
  • Genetics and Gene Therapy Research
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
  • Home
  • UMass

UMass

UMass Chan licenses gene therapy for rare genetic disorder to Raiden Science Foundation
  • Genetics and Gene Therapy Research

UMass Chan licenses gene therapy for rare genetic disorder to Raiden Science Foundation

admin February 14, 2026 0

Raiden Pham, who was diagnosed with UBA5 disorder in 2021, with his mother Linda Pham. Photo courtesy of Tommy and Linda...

Read MoreRead more about UMass Chan licenses gene therapy for rare genetic disorder to Raiden Science Foundation
Gene therapy developed for maple syrup urine disease shows promise, new UMass Chan study reports
  • Genetics and Gene Therapy Research

Gene therapy developed for maple syrup urine disease shows promise, new UMass Chan study reports

admin April 29, 2025 0

A study led by UMass Chan Medical School researchers demonstrated that a gene therapy to correct a mutation that causes...

Read MoreRead more about Gene therapy developed for maple syrup urine disease shows promise, new UMass Chan study reports
UMass Researchers Advance Gene Therapy for MSUD
  • Genetics and Gene Therapy Research

UMass Researchers Advance Gene Therapy for MSUD

admin March 26, 2025 0

Register for free to listen to this article Thank you. Listen to this article using the player above. ✖...

Read MoreRead more about UMass Researchers Advance Gene Therapy for MSUD
Family with child affected by SPG4 visits UMass Chan researchers developing gene therapy
  • Genetics and Gene Therapy Research

Family with child affected by SPG4 visits UMass Chan researchers developing gene therapy

admin October 24, 2024 0

Jack Laidlaw, 7, of Ottawa, Ontario, visited UMass Chan with his family to meet researchers working on a gene therapy...

Read MoreRead more about Family with child affected by SPG4 visits UMass Chan researchers developing gene therapy

Recent Posts

  • CDC in Nigeria | Global Health
  • Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Global Health Updates: US & WHO News
  • Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Archives

  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023

Categories

  • Genetics and Gene Therapy Research
  • Global Health and the Health Crisis
  • Health Horizon
  • Health Technology Innovation
  • Mental Health and Emotional Wellbeing
  • News

Visit Us

Advanced Business Operations

You may have missed

CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0
Global Health Updates: US & WHO News
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

admin February 22, 2026 0
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

admin February 21, 2026 0
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

admin February 21, 2026 0
Copyright © All rights reserved. | CoverNews by AF themes.